LONDON: The European Union's medication controller said on Monday it could issue "in practically no time" a choice on whether to support the utilization of Pfizer's Covid-19 pill, Paxlovid, after the US drugmaker presented an application looking for authorisation.
The endorsement looked for will be for the treatment of gentle to-direct Covid-19 in patients 12 years old and more established, weighing something like 40 kilograms and are at high danger of their ailment deteriorating, the European Medicines Agency said.
